Sort
46,585 grants matching “heart failure”
Optimizing Beta-Adrenoceptor Signaling Bias in Asthma
$655,249Julia K L Walker · Duke University · R01 · FY2015 · AI
Deciphering the genetic mechanisms of atrial fibrillation
$655,247Dawood Darbar · University Of Illinois At Chicago · R01 · FY2020 · HL
Protein therapy to treat virus induced cardiopulmonary injury
$655,228Jianjie Ma · University Of Virginia · R01 · FY2023 · HL
Protein therapy to treat virus induced cardiopulmonary injury
$655,228Jianjie Ma · University Of Virginia · R01 · FY2025 · HL
Biomimetic Membrane Device for Therapeutic Application in Chronic Heart Failure
$655,205Deborah A Buffington · Innovative Biotherapies, Inc. · R43 · FY2015 · HL
A mixed-methods study of the nature, extent and consequences of artificial intelligence (AI) for individualized treatment planning in end-of-life and palliative care (EOLPC)
$655,199Matthew Wayne Decamp · University Of Colorado Denver · R01 · FY2023 · NR
Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease
$655,186Rheem Angela Totah · University Of Washington · R01 · FY2025 · HL
Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease
$655,165Brad C Astor · Johns Hopkins University · R01 · FY2007 · DK
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
$655,060Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · DK
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
$655,037Theresa A Guise · Indiana University Indianapolis · R01 · FY2016 · CA
Molecular and Cellular Basis of Cardiovascular Disease
$654,974Brian L Black · University Of California, San Francisco · T32 · FY2021 · HL
Anti-inflammatory therapy to augment CFTR rescue in CF patients
$654,969Matthias A Salathe · University Of Kansas Medical Center · R01 · FY2019 · HL
Sedentary behavior, physical activity, sleep, and cardiovascular risk in pregnancy: the Pregnancy 24/7 cohort study
$654,919Kara Marie Whitaker · University Of Iowa · R01 · FY2023 · HL
Impact of metabolic acidosis on muscle mitochondrial energetics, metabolic health and physical endurance in persons with chronic kidney disease
$654,867Baback Roshanravan · University Of California At Davis · R01 · FY2022 · DK
ARTERY Outcomes: tAilored dRug Titration through artificial intElligence: an inteRventional studY
$654,816Gabriela Voskerician · Optima Integrated Health, Inc. · R44 · FY2020 · HL
Sensor-controlled digital game for heart failure self-management behavior adherence: A randomized controlled trial
$654,788Kavita Radhakrishnan · University Of Texas At Austin · R01 · FY2025 · HL
Epigenetic-mediated Notch pathway activation promotes elastin aortopathy
$654,729Daniel Greif · Yale University · R01 · FY2023 · HD
Epigenetic-mediated Notch pathway activation promotes elastin aortopathy
$654,729Daniel Greif · Yale University · R01 · FY2025 · HD
CaMKII-dB and CaMKII-dC Oppositely Regulate Cardiomyocyte viability
$654,709Rui-Ping Xiao · Aging · Z01 · FY2007 · AG
The Molecular Basis of Cardiac Senescence: From Transcriptomics to Function
$654,709Kenneth R Boheler · Aging · Z01 · FY2007 · AG
MItochondrial Dysfunction in Cardiac Hypertrophy and Failure
$654,631Brian O'Rourke · Johns Hopkins University · R01 · FY2011 · HL
Roles for SGK1 in Cardiometabolic Heart Failure with Preserved Ejection Fraction
$654,530Erik Blackwood · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL
Kidney Injury in Patients with Acute Decompensated Heart Failure
$654,364Nisha Bansal · University Of Washington · R01 · FY2022 · DK
Collective Ryanodine Receptor Operation at Release Sites
$654,349Michael Fill · Rush University Medical Center · R01 · FY2024 · HL
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$654,307Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL